Join to View Full Profile
1120 Nw 14th StMiami, FL 33136
Phone+1 305-243-4951
Fax+1 305-243-7432
Dr. De La Fuente is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Universidad Nacional de La Plata Faculty of MedicineClass of 2005
Certifications & Licensure
- FL State Medical License 2014 - 2026
- NY State Medical License 2013 - 2026
- American Board of Radiology Therapeutic Medical Physics
- UCNSNeuro-Oncology Diplomate
Clinical Trials
- Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors Start of enrollment: 2020 Jun 16
Roles: Principal Investigator, Contact
- Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment Start of enrollment: 2024 Jan 04
Roles: Principal Investigator, Contact
- STARLITE for Unresectable High-Grade Gliomas Start of enrollment: 2025 Jul 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 5 citationsDelineation of recurrent glioblastoma by whole brain spectroscopic magnetic resonance imaging.Jonathan B Bell, William Jin, Mohammed Z Goryawala, Gregory A Azzam, Matthew C Abramowitz
Radiation Oncology. 2023-02-22 - 1 citationsA Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma.Karthik K Ramesh, Vicki Huang, Jeffrey Rosenthal, Eric A Mellon, Mohammed Goryawala
Tomography. 2023-02-06 - 49 citationsOlutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial.Macarena I de la Fuente, Howard Colman, Mark Rosenthal, Brian A Van Tine, Danijela Levacic
Neuro-Oncology. 2023-01-05
Grant Support
- A Phase 2 biomarker driven, Study of DB107, a Retroviral Replicating Vector, Combined With 5-FC in Patients with Recurrent Glioblastoma or Anaplastic AstrocytomaUNIVERSITY OF MIAMI SCHOOL OF MEDICINE2023–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: